Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.

TCGA-44-4112-01A-01R-A278-07

· cohortMD2

c98a695b-db32-5656-95ef-ede8b178a77c

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
cohortMD2
subtype
cohortMD2

GSVA pathway preview (0 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

HTTPException: HTTP Error: Request returned HTTP 429 for HTTP HEAD to 'https://pub-e056b053afc04eec88337b62541f3025.r2.dev/oncoscape/lung-landscapes/6/gsva.parquet' LINE 1: SELECT pathway_library_id, pathway_name, gsva_score FROM read_parquet('https://pub-e056b053afc04eec88337b62541f3025... ^

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

7 twins match this tumor's tissue · 3 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1TCGA-A7-A26E-01A-11R-A277-07
breast-umap@18
D0.781
2SJEPD030580_D1.RNA-Seq
medullo-epn-umap@date-based
EPNEPN Tumor0.757
3TCGA-BL-A0C8-01A-11R-A277-07
bladder-landscape@3
0.748
4SJEPD031367_D1.RNA-Seq
medullo-epn-umap@date-based
EPNAnaplastic EPN0.745
5TCGA-44-2665-01A-01R-A278-07
lung-landscapes@6
cohortMD20.724
6BS_KYF0Q0E7
medullo-epn-umap@date-based
MedMedulloblastoma0.714
7SRR1797227
lung-landscapes@6
cohortSC0.706
8SRR1516042
bladder-landscape@3
0.704
9b503bcc9-714d-40aa-8709-3b4577ce8007
colon-landscapes@1
0.700
10R157
bladder-landscape@3
0.699

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 17 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
PROTEIN_SECRETION0.450Remibrutinib— uncovered
UV_RESPONSE_DN0.300Inavolisib— uncovered
ANDROGEN_RESPONSE0.240Inavolisib— uncovered
TGF_BETA_SIGNALING0.220Inavolisib— uncovered
HEME_METABOLISM0.180Temsirolimus— uncovered
MITOTIC_SPINDLE0.180Inavolisib— uncovered
OXIDATIVE_PHOSPHORYLATION0.160Remibrutinib— uncovered
EPITHELIAL_MESENCHYMAL_TRANSITION0.140Inavolisib— uncovered
PI3K_AKT_MTOR_SIGNALING0.140Inavolisib— uncovered
BILE_ACID_METABOLISM0.100Inavolisib— uncovered
PEROXISOME0.060Idelalisib— uncovered
GLYCOLYSIS0.050Inavolisib— uncovered
MYC_TARGETS_V10.040Inavolisib— uncovered
ADIPOGENESIS0.030Inavolisib— uncovered
NOTCH_SIGNALING0.030Inavolisib— uncovered
KRAS_SIGNALING_UP0.020Inavolisib— uncovered
SPERMATOGENESIS0.020Inavolisib— uncovered